Veterinary Diagnostic Market by Product, Animal Type, Testing Category, Disease Type, End-Use

List of Tables

[192 Pages Report] The Veterinary Diagnostic Market size was estimated at USD 5.48 billion in 2023 and expected to reach USD 6.24 billion in 2024, at a CAGR 15.24% to reach USD 14.80 billion by 2030.

Veterinary diagnostics refers to the various methods, techniques, and tools employed to identify and diagnose animal diseases, infections, or health conditions. These diagnostics play a crucial role in veterinary medicine by helping veterinarians and other animal health professionals make informed decisions about the care and treatment of animals. Veterinary diagnostics encompass various methods, including laboratory tests, imaging techniques, and clinical examinations. The increase in pet ownership, enhanced awareness about animal health, and growing expenditure on animal healthcare are collectively pushing the market forward. There are also regulatory mandates regarding food safety that directly impact the growth of the veterinary diagnostics market. The high cost of animal testing, a shortage of professional expertise in veterinary pathology, unclear reimbursement scenarios, and limited awareness in developing countries hamper its market demand. The lack of standardized tests and stringent regulatory procedures pose significant challenges for the stakeholders of the veterinary diagnostic market. The considerable demand for rapid diagnostics over laboratory-based tests, increasing prospects in untapped emerging markets, point-of-care services, and the rising need for disease control in livestock are expected to create an opportunity in the market.

KEY MARKET STATISTICS
Base Year [2023]	USD 5.48 billion
Estimated Year [2024]	USD 6.24 billion
Forecast Year [2030]	USD 14.80 billion
CAGR (%)	15.24%

Product: Consumables, reagents, and kits providing accuracy and speed in diagnosis

Consumables, reagents, and kits are indispensable in the veterinary diagnostics market. These products are primarily used for sample preparation & testing, offering precise and accurate results for various veterinary conditions. Demand largely hinges on the frequency of diagnostic procedures, with higher case volumes leading to increased need. Instruments and devices form the bedrock of diagnostics, providing the tools veterinarians need to assess and diagnose conditions effectively. This segment includes many products, from basic surgical instruments to complex imaging devices. Software & services represent a rapidly growing segment in veterinary diagnostics, encompassing practice management software, diagnostic services, and telemedicine services. These products are vital in managing clinic workflows and enhancing patient care.

Animal Type: Significant adoption of veterinary diagnostics for livestock animals health management

Using veterinary diagnostics for companion animals, such as cats and dogs, is integral to maintaining their health, preventing diseases, and diagnosing conditions early. Owners demonstrate the highest preference for non-invasive and less stressful diagnostic methods for their pets. These services suit the specific needs of dogs, cats, and other pets in a household setup. The usage of veterinary diagnostics in cats and dogs is comprehensive, covering a wide range of areas to ensure comprehensive healthcare. These diagnostics help veterinarians tailor treatment plans, offer preventive care, and improve the quality of life for companion animals. Veterinary diagnostics are crucial in livestock animals' health management and disease control, including cattle, poultry, and swine. These diagnostics help farmers and veterinarians monitor the health status of herds, detect diseases early, and implement appropriate interventions.

Disease Type: Veterinary vaccines are primarily utilized to reduce the risk of infectious diseases in animals

General ailments, such as gastroenteritis, parasites, and respiratory disorders, constitute common illnesses that affect animals regularly. Veterinary diagnostics for general ailments are essential and in high demand due to their frequency and the need for prompt treatment. Hereditary, congenital & acquired diseases are inherited, present at birth, or obtained during the animal's lifetime. Diagnostic procedures for these diseases often need advanced equipment and molecular diagnostic tests. Veterinary diagnostics are essential for detecting, monitoring, and controlling animal infectious diseases. These diagnostic tools are crucial in identifying pathogens, assessing the extent of infections, and implementing appropriate disease management strategies. Non-infectious diseases include conditions such as cancer, diabetes, and heart disease. Veterinary diagnostics of non-infectious illnesses are crucial for identifying underlying health issues, developing treatment plans, and improving animals' overall quality of life. Veterinary diagnostics are essential for identifying and managing structural and functional animal diseases. Structural diseases involve abnormalities in the anatomy or physical structure of organs and tissues, while functional disorders involve disruptions in the normal functioning of physiological processes.

End-Use: Potential utilization of veterinary diagnostic in veterinary hospitals & clinics

Point-of-care or in-house testing (POCT) is a crucial part of modern veterinary practices, aiming to deliver rapid, accurate results within the comfort of the patient's home or veterinary clinic, minimizing the stress for both the pet and the owner. The need-based preference for POCT in the veterinary diagnostic field is driven by its advantages, such as speed, precision, and convenience. Beyond offering rapid diagnostics for efficient treatment, POCT systems can also aid the veterinarian in monitoring vital biochemistry parameters during surgical or critical cases. Research centers and universities contribute significantly to the progress of veterinary diagnostics by investing in cutting-edge, research-oriented technologies. Their preference reflects a need for advanced diagnostic tools to diagnose emerging and re-emerging zoonotic diseases in various animal species. Veterinary hospitals and clinics represent a vital end-use segment for veterinary diagnostics. The specific needs of these settings prioritize reliable, cost-effective, and efficient diagnostic tools capable of handling high caseloads. Veterinary reference laboratories are essential in disease surveillance, diagnosis, and control. These laboratories often handle complex and rare cases, demanding a broader range and higher complexity of diagnostics.

Regional Insights

The veterinary diagnostic market in the Americas shows robust growth driven by advanced substantial pet ownership and livestock industry, adopting innovative diagnostic solutions swiftly. Progressive farm management practices, increasing pet adoption, and supportive government regulations further fueled the market demand in the region. The EMEA represents a dynamic diversity in the veterinary diagnostics space due to prolific regulatory structures and the adoption of preventive veterinary care; the growing awareness of zoonotic diseases and improved accessibility of advanced veterinary services contribute to this upward trend. Asia-Pacific presents a significant opportunity for the veterinary diagnostic market. The region is marked by rapid urbanization, rising disposable incomes, and a shift in lifestyle, which have all led to increased pet ownership and demand for quality animal healthcare. The livestock industry is pivotal in countries requiring efficient disease prevention and control diagnostic measures. The adoption of rapid tests and portable instruments is significantly notable, driving market growth in this region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Veterinary Diagnostic Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Veterinary Diagnostic Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Diagnostic Market, highlighting leading vendors and their innovative profiles. These include Agrolabo S.p.A., Bio-Rad Laboratories, Inc., Biogal Galed Labs, BioMerieux S.A., BioNote, Inc., Demeditec Diagnostics GmbH, Eurofins Technologies, Fassisi GmbH, FUJIFILM Holdings Corporation, Heska Corporation, IDEXX Laboratories, Inc., IDvet, Late Dr. (Major) S.K., Neogen Corporation, Nisseiken Co., Ltd, Qiagen N.V., Randox Laboratories, Ltd., Shenzhen Bioeasy Biotechnology Co., Ltd., Shenzhen Mindray Animal Medical Technology Co., Ltd., SKYER, Inc., Skyla Corporation, Thermo Fisher Scientific Inc., Vimian Group AB, Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary Diagnostic Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Consumables, Reagents & Kits
- Instruments & Devices
- Software & Services

Animal Type
- Companion Animals
  - Cats
  - Dogs

Livestock Animals
- Cattle
- Poultry
- Swine

Testing Category
- Analytical Services
- Bacteriology
- Diagnostic Imaging
- Immunoassays
- Molecular Diagnostics
- Parasitology
- Pathology
- Serology
- Virology

Disease Type
- General Ailments
- Hereditary, Congenital & Acquired Diseases
- Infectious Diseases
- Non-Infectious Diseases
- Structural & Functional Diseases

End-Use
- Point-of-Care/In-House Testing
- Research Centers & Universities
- Veterinary Hospitals & Clinics
- Veterinary Reference Laboratories

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Veterinary Diagnostic Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Veterinary Diagnostic Market?

3. What are the technology trends and regulatory frameworks in the Veterinary Diagnostic Market?

4. What is the market share of the leading vendors in the Veterinary Diagnostic Market?

5. Which modes and strategic moves are suitable for entering the Veterinary Diagnostic Market?

Product Code: MRR-034B50030395

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rise in pet ownership and enhanced awareness about animal health
  - 5.1.1.2. Increasing incidence of animal diseases in economies
  - 5.1.1.3. Surge in animal healthcare expenditure coupled with rising disposable income
- 5.1.2. Restraints
  - 5.1.2.1. High cost associated with veterinary diagnostic testing
- 5.1.3. Opportunities
  - 5.1.3.1. Introduction of pet insurance and advanced development of new diagnostic assay
  - 5.1.3.2. Emerging use of in vitro diagnostic tests and the rising number of veterinary laboratories
- 5.1.4. Challenges
  - 5.1.4.1. Lack of standardized tests and dearth of veterinarians in economies
5.2. Market Segmentation Analysis
- 5.2.1. Product: Consumables, reagents, and kits providing accuracy and speed in diagnosis
- 5.2.2. Animal Type: Significant adoption of veterinary diagnostics for livestock animals health management
- 5.2.3. Disease Type: Veterinary vaccines are primarily utilized to reduce the risk of infectious diseases in animals
- 5.2.4. End-Use: Potential utilization of veterinary diagnostic in veterinary hospitals & clinics
5.3. Market Disruption Analysis
5.4. Porter's Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Veterinary Diagnostic Market, by Product

6.1. Introduction
6.2. Consumables, Reagents & Kits
6.3. Instruments & Devices
6.4. Software & Services

7. Veterinary Diagnostic Market, by Animal Type

7.1. Introduction
7.2. Companion Animals
7.3. Livestock Animals

9. Veterinary Diagnostic Market, by Disease Type

9.1. Introduction
9.2. General Ailments
9.3. Hereditary, Congenital & Acquired Diseases
9.4. Infectious Diseases
9.5. Non-Infectious Diseases
9.6. Structural & Functional Diseases

10. Veterinary Diagnostic Market, by End-Use

10.1. Introduction
10.2. Point-of-Care/In-House Testing
10.3. Research Centers & Universities
10.4. Veterinary Hospitals & Clinics
10.5. Veterinary Reference Laboratories

11. Americas Veterinary Diagnostic Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Veterinary Diagnostic Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Veterinary Diagnostic Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
- 14.3.1. Royal Canin Collaborated with GekkoVet to Bring AI-Powered Solution For Vets
- 14.3.2. IDEXX Announces Novel Diagnostic Test for Kidney Injury, Expanding the Veterinary Industry's Most Comprehensive Renal Testing Portfolio
- 14.3.3. Mars to Acquire Heska, Global Provider of Advanced Veterinary Diagnostic and Specialty Solutions
14.4. Strategy Analysis & Recommendation

15. Competitive Portfolio

15.1. Key Company Profiles
15.2. Key Product Portfolio